Navega Therapeutics

0 followers


Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.

Industries

Headquarters

Stage

Employees

Links

Org chart

Ana Moreno
Founder & CEO

Ana Moreno

Collapse
Fernando Aleman
Co-founder & CSO
Sarah DuFresne
Operations Manager